FDA
approval
· 2021-03-15
FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)
Summary
FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VASOSTRICT (VASOPRESSIN)